It’s no secret that drug manufacturers and distributors earn incredible profit margins on medication sales. Even when generic versions are …
Testosterone Gel Heart Attack Victim Wins $140MM Settlement
In October 2017, a Chicago jury ordered testosterone gel manufacturer AbbVie, Inc. to pay more than $140 million in damages. …
Docetaxel Chemo Claims May Reach Settlements Before Upcoming Trials
Despite gaining the U.S. Food and Drug Administration’s approval in 1996, Taxotere (generic: docetaxel) has spent years embroiled in litigation. …
Low T Fatalities Make Men Think Twice About Therapies
Low testosterone levels can cause significant health problems for aging men. All men experience a testosterone decline as they age. …
Rising Healthcare Costs Predicted for 2018
As if they’re not high enough, healthcare costs are predicted to rise in 2018. A new study by PricewaterhouseCoopers Health …
Generic Docetaxel Hair Loss Victims Can Now Join Taxotere MDL
The multidistrict litigation (MDL) for popular breast cancer drug Taxotere (docetaxel) is heating up. A federal judge already selected several …
Low Testosterone Blood Clots and a Mistaken Fountain of Youth
For many men, aging brings lower testosterone levels. And in recent years, testosterone replacement therapies became an alluring fountain of …
Chronic Myeloid Leukemia: Who’s At Risk, and What Are the Signs?
Chronic myeloid leukemia (CML) is a blood cancer that affects about 200,000 new people each year. This difficult-to-treat disease starts …
Temporal Arteritis Study: Actemra Works 3x Better Than Corticosteroids
Inflammation within the arteries can cause a condition called giant cell arteritis (also known as temporal arteritis). For most patients, …
Study: Leukemia Treatment Tasigna May Treat Parkinson’s, Alzheimer’s
A June 2016 study looked at controversial leukemia treatment Tasigna (nilotinib) to measure its effect on Parkinson’s symptoms. According to …